Related Experiment Videos

Genetic mechanisms of tumor suppression by the human p53 gene

P L Chen1, Y M Chen, R Bookstein

  • 1Department of Pathology, School of Medicine, University of California, San Diego, La Jolla 92093-0612.

Science (New York, N.Y.)
|December 14, 1990
PubMed

Insights

Mutations in the p53 gene are common in human tumors. Both p53 gene copies must be inactivated for cancer development, similar to the retinoblastoma gene.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The p53 gene, encoding a 53-kilodalton protein, is frequently mutated in human tumors.
  • These mutations suggest a critical role for p53 in human oncogenesis.

Purpose of the Study:

  • To model the stepwise mutation or loss of both p53 alleles during tumorigenesis.
  • To investigate the functional consequences of wild-type versus mutated p53 expression.

Main Methods:

  • Utilized a human osteosarcoma cell line (Saos-2) lacking endogenous p53.
  • Introduced single copies of exogenous p53 genes (wild-type and point-mutated) via recombinant retroviruses.

Main Results:

  • Wild-type p53 expression suppressed the neoplastic phenotype of Saos-2 cells.
  • Mutated p53 conferred a limited growth advantage in the absence of wild-type p53.
  • Wild-type p53 demonstrated phenotypic dominance over mutated p53 in a two-allele system.

Conclusions:

  • Inactivation of both p53 alleles appears essential for its role in oncogenesis.
  • This mechanism parallels the tumor suppressor function observed for the retinoblastoma gene.

Related Concept Videos